Email this page
  Print-friendly version
  Download Adobe Reader

The mission of the Office of Translational Research is to facilitate the preclinical discovery and development of new therapeutic interventions for neurological disorders by:

• Supporting preclinical development from discovery candidate therapeutics through Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications to the FDA
• Supporting the design, implementation, and management of research infrastructure activities that apply advanced research technologies to problems in neuroscience and neurology
• Supporting translational research projects and networks

Quick Links

Office of Translational Research Funding Initiatives

• All Office of Translational Research funding initiatives

Office of Translational Research Program Staff

Scientific Staff	Research Area
Jill Heemskerk, Ph.D. Program Director	High Throughput Drug Screening, SMA therapeutics development, Medicinal Chemistry
David Jett, Ph.D. Program Director	Counterterrorism (CounterACT) Programs, Neurotoxicology
Yuan Liu, Ph.D. Chief, Office of International Activities	Neuroimaging informatics, Bioinformatics, Computational Neuroscience
Thomas Miller, Ph.D., M.B.A. Program Director	Preclinical Development of Therapeutics, Research Infrastructure
Mark Scheideler, Ph.D. Program Analyst	Roadmap Molecular Libraries
James Stables, MS Admin., R.Ph. Program Director, Office Director	Anti-Convulsant Screening Program
Stacey Chambers Program Analyst
Lydia Munger Program Analyst

Address

NINDS Office of Translational Research Neuroscience Center
6001 Executive Blvd Bethesda, Maryland 20892
For courier service only, use Rockville, Maryland 20852
Phone: (301) 496-1779